Viewing Study NCT06221969

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 10:58 PM

Ignite Modification Date: 2026-01-02 @ 12:56 PM

Study NCT ID: NCT06221969

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-12-17

First Post: 2024-01-15

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Sponsor: Novo Nordisk A/S

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module